Who is Sonar? Sonar is driving the future of agent-centric software development. As the leader in AI code verification and governance, we solve a critical problem: ensuring that software generated by AI-assisted developers or autonomous agents
Who is Sonar? Sonar is driving the future of agent-centric software development. As the leader in AI code review and verification, we solve a critical problem: ensuring that software generated by AI-assisted developers or autonomous agents
Who is Sonar? Sonar is driving the future of agent-centric software development. As the leader in AI code review and verification, we solve a critical problem: ensuring that software generated by AI-assisted developers or autonomous agents
Who is Sonar? Sonar is driving the future of agent-centric software development. As the leader in AI code review and verification, we solve a critical problem: ensuring that software generated by AI-assisted developers or autonomous agents
Who/What is Artefact? Artefact is a next-generation strategy and data consulting firm dedicated to transforming organizations through data and AI. We combine the rigor of top-tier strategy consulting with deep expertise in data, digital, and analytics
Country Switzerland City GENEVE Area Switzerland Workplace location GENEVE-WTC1(CHE) Employer company TOTSA TotalEnergies Trading SA Domain Sales Type of contract Internship Experience Less than 3 years Context & Environment Proposed internship duration: 6-12 months Starting date:
At Anexia, we take responsibility for all the challenges of the digital world – each and every day. That’s because we see ourselves as the “Digital Transformation Engine”. And how do we succeed in this mission?
Country Switzerland City GENEVE Area Switzerland Workplace location GENEVE-WTC1(CHE) Employer company TotalEnergies Gas & Power Ltd Domain Strategy Economics Business Type of contract Internship Experience Less than 3 years Context & Environment Location: Geneva, Switzerland Proposed
Who is Sonar? Sonar is driving the future of agent-centric software development. As the leader in AI code verification and governance, we solve a critical problem: ensuring that software generated by AI-assisted developers or autonomous agents
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors
Country Switzerland City GENEVE Area Switzerland Workplace location GENEVE-WTC1(CHE) Employer company TOTSA TotalEnergies Trading SA Domain Secretarial/Administrative Support Type of contract Fixed term position Experience Less than 3 years Context & Environment TotalEnergies has developed strong expertise
Who/What is Artefact? Artefact is a next-generation strategy and data consulting firm dedicated to transforming organizations through data and AI. We combine the rigor of top-tier strategy consulting with deep expertise in data, digital, and analytics
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors
Who is Sonar? Sonar is driving the future of agent-centric software development. As the leader in AI code verification and governance, we solve a critical problem: ensuring that software generated by AI-assisted developers or autonomous agents